Filing Details
- Accession Number:
- 0000891293-23-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-26 17:17:19
- Reporting Period:
- 2023-01-24
- Accepted Time:
- 2023-01-26 17:17:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 891293 | Cti Biopharma Corp | CTIC | Pharmaceutical Preparations (2834) | 911533912 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1339498 | R Adam Craig | 3101 Western Avenue Suite 800 Seattle WA 98121 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-01-24 | 83,200 | $0.84 | 112,640 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-01-24 | 83,200 | $6.00 | 29,440 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-01-24 | 2,117 | $0.84 | 31,557 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-01-24 | 2,117 | $6.01 | 29,440 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-01-24 | 83,200 | $0.00 | 83,200 | $0.84 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-01-24 | 2,117 | $0.00 | 2,117 | $0.84 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 472,171 | 2029-05-16 | No | 4 | M | Direct | |
| 470,054 | 2029-05-16 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a 10b5-1 sales plan adopted by the Reporting Person.
- One third of the shares underlying the option vested on 2/19/20 and annually thereafter until all the underlying shares were fully vested on 2/19/2022.
Billionaire Hedge Funds
